Lentigo maligna survival: Balancing treatment decisions in those with limited life expectancy

Kate Quirke; James Powell; Dimitrios Karponis; Martyn Patel; Birgitta van Bodegraven; Zoe C. Venables

doi:10.1093/bjd/ljaf489

Lentigo maligna survival: Balancing treatment decisions in those with limited life expectancy

Kate Quirke, James Powell, Dimitrios Karponis, Martyn Patel, Birgitta van Bodegraven, Zoe C. Venables

Research output: Contribution to journal › Article › peer-review

Abstract

This study assesses incidence, overall and net survival in patients with lentigo maligna in England. Data shows excellent five-year net survival in all ages (>100%), but overall survival in those aged 80+ is only 60.4%, reflecting the impact of comorbidities and limited life expectancy. These findings highlight the need for lentigo maligna management guidelines to incorporate frailty assessment and support shared decision-making in older adults, including consideration of non-surgical approaches.

Original language	English
Journal	British Journal of Dermatology
Early online date	1 Dec 2025
DOIs	https://doi.org/10.1093/bjd/ljaf489
Publication status	E-pub ahead of print - 1 Dec 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/bjd/ljaf489Licence: Unspecified

https://academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljaf489/8362393Licence: Unspecified

Cite this

@article{9f903f7d386248909a4474ebb77b3a88,

title = "Lentigo maligna survival: Balancing treatment decisions in those with limited life expectancy",

abstract = "This study assesses incidence, overall and net survival in patients with lentigo maligna in England. Data shows excellent five-year net survival in all ages (>100%), but overall survival in those aged 80+ is only 60.4%, reflecting the impact of comorbidities and limited life expectancy. These findings highlight the need for lentigo maligna management guidelines to incorporate frailty assessment and support shared decision-making in older adults, including consideration of non-surgical approaches.",

author = "Kate Quirke and James Powell and Dimitrios Karponis and Martyn Patel and {van Bodegraven}, Birgitta and Venables, {Zoe C.}",

year = "2025",

month = dec,

day = "1",

doi = "10.1093/bjd/ljaf489",

language = "English",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley",

}

TY - JOUR

T1 - Lentigo maligna survival: Balancing treatment decisions in those with limited life expectancy

AU - Quirke, Kate

AU - Powell, James

AU - Karponis, Dimitrios

AU - Patel, Martyn

AU - van Bodegraven, Birgitta

AU - Venables, Zoe C.

PY - 2025/12/1

Y1 - 2025/12/1

N2 - This study assesses incidence, overall and net survival in patients with lentigo maligna in England. Data shows excellent five-year net survival in all ages (>100%), but overall survival in those aged 80+ is only 60.4%, reflecting the impact of comorbidities and limited life expectancy. These findings highlight the need for lentigo maligna management guidelines to incorporate frailty assessment and support shared decision-making in older adults, including consideration of non-surgical approaches.

AB - This study assesses incidence, overall and net survival in patients with lentigo maligna in England. Data shows excellent five-year net survival in all ages (>100%), but overall survival in those aged 80+ is only 60.4%, reflecting the impact of comorbidities and limited life expectancy. These findings highlight the need for lentigo maligna management guidelines to incorporate frailty assessment and support shared decision-making in older adults, including consideration of non-surgical approaches.

U2 - 10.1093/bjd/ljaf489

DO - 10.1093/bjd/ljaf489

M3 - Article

SN - 0007-0963

JO - British Journal of Dermatology

JF - British Journal of Dermatology

ER -